- PR Newswire•9 days ago
CAMBRIDGE, Mass., Jan. 9, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today outlined anticipated milestones for IPI-549, a potentially first-in-class immuno-oncology product candidate ...
- TheStreet.com•10 days ago
Insiders at Infinity Pharmaceuticals and Och-Ziff Capital Management Group -- among other companies -- have been scooping up shares of their own stock lately.
- PR Newswire•13 days ago
CAMBRIDGE, Mass., Jan. 5, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 35 th Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2017, at 10:30 ...
INFI : Summary for Infinity Pharmaceuticals, Inc. - Yahoo Finance
Infinity Pharmaceuticals, Inc. (INFI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||1.37 x 900|
|Ask||1.75 x 200|
|Day's Range||1.65 - 1.81|
|52 Week Range||0.84 - 7.07|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.83|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|